Other content tagged: RSV
Advanced Policy and Advocacy Workshop on RSV 2.0 in Munich
From 12 to 15 September 2024, parent and patient representatives from 18 countries across 2 continents came together to exchange knowledge and learn about effective policy and advocacy activities, using RSV in young children as a case study. It was a pleasure for EFCNI to host this workshop on RSV policy and advocacy in Munich. The four days were packed with practical exercises, engaging group discussions, and workshops aimed at helping participants develop new or enhance existing tools and skills…
Read more
Know the facts in a world full of infectious respiratory viruses
Explore our corporate partner AstraZeneca's new one-stop web resource for respiratory virus knowledge and try the symptom comparator right away. It's that time of year again when coughs and colds are ubiquitous. But is it possible to have several respiratory diseases at the same time? Indeed, this phenomenon is known as coinfection although it is relatively rare due to the competition between the viruses during infection.[1-3] While infrequent, the consequences of coinfection may…
Read more
RSV Policy and Advocacy Workshop in Munich
From 23 to 25 June 2023, parent and patient representatives from all over the world came together to exchange and learn about effective policy and advocacy activities and tools using the example of RSV in young children. It was a pleasure for EFCNI to host this workshop on policy and advocacy in the field of RSV in Munich from 23 to 25 June 2023. The three days were packed with practical exercises, interesting group discussions and workshops to help the…
Read more
New preliminary study results suggest that new RSV antibody may help reduce infant hospitalisation due to RSV
Interesting first preliminary results from the HARMONIE phase 3b trial on the efficacy of Nirsevimab against RSV (respiratory syncytial virus) infection were presented at the 41st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) in Lisbon in early May. According to these initial results, a single intramuscular dose of this new monoclonal antibody would significantly reduce the frequency of hospitalisations in infants with RSV-associated lower respiratory tract infections (LRTI), suggesting that…
Read more
Beneficial influence of breastfeeding on Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children – a systematic literature review
The Respiratory Syncytial Virus (RSV) poses a significant risk of serious infection in children worldwide, in particular in children in low-income and middle-income countries. However, previous studies indicated that breastfeeding could be a protective factor as it strengthens the immune system and protects against other serious childhood infections. A current systematic review summarises the available evidence on breastfeeding and its effects on acute lower respiratory infections which are associated with RSV. Breastfeeding is officially…
Read more
Platinum Partner AstraZeneca produced and funded “Sounds of RSV” to support awareness of symptoms
Our partnership with AstraZeneca is part of the EFCNI’s ongoing dedication to raising awareness amongst parents and healthcare professionals about the symptoms of RSV infection and how it can be prevented. With around 33 million acute lower respiratory infections caused each year, RSV infection is one of the most common causes of early life wheezing illness.[1,2] Babies who are born prematurely or who have underlying health issues such as heart or…
Read more
FIRST EXPERT ROUNDTABLE ON RSV PROTECTION FOR ALL INFANTS
In 2021, the season of respiratory syncytial virus (RSV) infections was exceptional in terms of the very early onset and the enormously high numbers of hospitalised children. Thus, the last season showed very clearly: RSV is a major health threat to children under two years of age. In most cases of RSV, children develop only mild, cold-like symptoms. However, a number of children suffer from a severe course of the infection with severe respiratory distress and accompanying symptoms that need…
Read more
